The Trusted Source For Health
CLARION — Butler Well being System’s Health and fitness and Wellness Heart at Trinity Place formally opened Friday. “We did not want to build a 1990s cookie-cutter medical place of work building,” Clarion Medical center President Steven Davis explained previously this 7 days. “We required …
It is almost the end of January and some individuals might be coming to the realization that New Year’s resolutions are much easier to make than continue to keep. Health and fitness experts generally clarify the goal must be a life-style adjust, which will take …
If you believed all the hype extolling its apparent virtues, CBD oil just might be the elixir of life. The cannabinoid compound is having a moment, with its global market projected to grow from $US1.4 billion in 2020 to $US12.9 billion by 2027, according to one market research group.
A 2020 analysis that looked at social media posts to better understand why people used the plant extract found reasons ranging from mental health issues, including anxiety and depression, to musculoskeletal problems as well as for gut issues, autism, addiction, heart problems, skin problems, eye problems, sleep and sexual health issues.
This was despite a lack of evidence behind many of the claims about CBD oil’s benefits and, in many cases, a lack of access to the real thing. A separate analysis found that only one-third of extracts sold online contained the amount of cannabidiol (CBD) that the label claimed – if they contained any at all. University of Newcastle clinical pharmacologist Professor Jennifer Martin recalls a patient who was “really pissed off” because he spent $90 on what he believed was CBD oil only to discover it was olive oil.
Whether the products or claims are real or not, the hype surrounding CBD oil certainly is. So, what is it? Where does it come from? And does it do anything?
Illustration: Jo GayCredit:
There are about 100 different cannabis-like (cannabinoids) compounds in hemp and cannabis plants. The two main ones are tetrahydrocannabinol (THC, found mostly in cannabis), which will make you high; and cannabidiol (CBD, found mostly in hemp), which will not make you high nor have psychotic effects. As the World Health Organisation states, “in humans, CBD exhibits no effects indicative of any abuse or dependence potential.”
Both THC and CBD fall under the umbrella of “medicinal cannabis”, which can contain THC only, CBD only, or various ratios of the two.
Although hemp has a higher CBD content, hemp oil is very different to CBD oil. Hemp oil is made by cold-pressing hemp seeds. CBD oil is made by extracting the compound from the hemp plant and then mixing it with a carrier oil. You can buy hemp seed oil at the supermarket to drizzle on your salad but it contains a negligible amount of actual CBD.
In CBD oils, the amount of cannabidiol varies from product to product. There is “purified” CBD, typically at least 98 per cent pure, and “full spectrum”, which contains other compounds from the plant, not just CBD.
“The purified preparation is the one that has been approved by the TGA [for epilepsy],” says associate professor Jonathon Arnold, the deputy academic director of the Lambert Initiative for Cannabinoid Therapeutics, a research centre at the University of Sydney set up with an investment by Barry and Joy Lambert, whose granddaughter suffered from debilitating paediatric epilepsy. Arnold adds that the full-spectrum preparations may be beneficial in their own right but need further research.
Loading
People have been using cannabis and its compounds for millennia, first documented in the case of Emperor Shen Nung in 2800BC.
In the 1800s, cannabis extracts, including CBD, were being used in Western medicine, but prohibition put a stop to that (Australian federal laws banned cannabis importation and use in 1926). People continued smoking marijuana and extracts were made and sold illegally. So, why the sudden interest in these compounds now?
The “father of cannabis”, Israeli researcher Raphael Mechoulam, discovered THC in the 1960s and then made other groundbreaking discoveries in the ’80s and ’90s, identifying the various cannabinoids in cannabis as well as the endocannabinoid system (ECS). The ECS is the naturally occurring cannabis in our bodies – made up of molecules, receptors and enzymes – that plays a role in regulating mood, motivation, pleasure, sleep, appetite and metabolism.
It wasn’t until 2015, that Australia’s Therapeutic Goods Administration (TGA) approved CBD as a prescription medicine.
Unless it is prescribed by a doctor, people who want CBD have to obtain it elsewhere, including buying unregulated products online from overseas suppliers.
In recent years, there has been a proliferation in research and a corresponding surge in supply and demand for the product. Low-dose CBD has since been approved as a Schedule 3 (pharmacist-only) medicine, and in 2021 Australia’s largest pharmacy chain, Chemist Warehouse, signed a deal to supply the products over the counter. But you won’t see them in any pharmacy yet. This is because no CBD product has been approved by the Australian Register of Therapeutic Goods (ARTG), which is a requirement of pharmacist sale. When, and if, ARTG gives its approval, “low-dose” CBD products (less than 150 mg per day), from companies that also have TGA approval, will become available over the counter in pharmacies.
Until then, doctors can prescribe it for a range of issues including epilepsy, chronic pain, anxiety and insomnia. Otherwise, people who want CBD have to obtain it elsewhere, including buying unregulated products online from overseas suppliers. Mail-order and online cannabis products are illegal in Australia.
It is, Arnold admits, “all quite complex”.
In many countries, CBD is available as an over-the-counter “nutraceutical”. These contain very low doses (just a fraction of the therapeutic dose range) for which there is little evidence of health benefits. The lack of therapeutic effect with such low-dose products is not the only issue, says Professor Stephen Myers, a complementary medicine expert from the NICM Health Research Institute.
“Obtaining your CBD oil other than through a medical prescriber is fraught with a number of problems,” Myers says. “The preparation is unlikely to have been manufactured under pharmaceutical-grade quality.”
And what you might think is pure CBD oil could have contaminants including, but not limited to, THC. “A lot of people don’t want the psychoactive effect of cannabis, they’re more after the anxiolytic effect – the reducing anxiety effect.“
CBD is what pharmacologists like to call a “promiscuous drug”, explains Arnold.
It is referred to as a “promiscuous drug” partly because the endocannabinoid system (ECS) is widespread in the body and CBD seems to interact with a variety of its target receptors and enzymes.
“CBD is a really interesting compound because there have been more than 65 different potential mechanisms of action that it has,” Arnold says. “CBD doesn’t directly activate the cannabinoid receptors. It might be boosting your endocannabinoids.”
Our endocannabinoids interact with cannabinoid receptors to influence biological function. When we boost our levels of endocannabinoids (endo means “within”), this may result in less inflammation and pain in the body, an enhanced sense of wellbeing and support the body to regulate its functions.
“Ananda is the Sanksrit word for bliss – and it increases levels of anandamide clearly in the body.”
“[The ECS] is all through the brain and in the immune system and in most parts of the body,” says pharmacologist and cannabinoid researcher Mark Connor from Macquarie University. “It has a zillion functions. It’s in parts of the brain that are important in anxiety, it’s in parts of the brain that are important in mediating reward, it’s in parts of the brain that are important in modulating pain.” He adds: “Any drug that interacts with that system has, potentially, a wide range of effects.”
By taking CBD oil, we boost our blood levels of endocannabinoids, Arnold says. “One of them is called anandamide – ananda is the Sanksrit word for bliss – and it increases levels of anandamide in the body,” he explains. “The idea then is that you’re toning up these levels of naturally occurring endocannabinoids and that could be exerting its beneficial effects.”
Social contact, chocolate and exercise can also stimulate anandamide.
CBD also has anti-inflammatory properties and, Arnold adds, inflammation can be common to a range of different health conditions.
He says CBD also behaves similarly to Valium “but it’s not as potent, and it acts on this inhibitory receptor called the GABA receptor, and it’s able to tone up the actions of that receptor.” GABA receptors help to inhibit or reduce nerve impulses and have a natural calming effect.
(Alcohol ultimately depletes GABA stores, and because these stores have a calming function, this results in anxiety.)
There is good evidence that CBD does help with epilepsy by reducing seizures, and this is what it is approved for medically.
Loading
Australian Medical Association president Dr Omar Khorshid points out that only two medicinal cannabis products have been approved by the TGA and registered on the ARTG: “Nabiximols (for patients with moderate to severe spasticity due to multiple sclerosis) and Epidyolex (for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome).”
All other medicinal cannabis products available in Australia are unregistered medicines. Still, legal access to medicinal cannabis is increasing and GPs can prescribe a range of CBD oils via the Special Access Scheme or Authorised Prescriber Schemes for different conditions, including neuropathic pain, chronic pain, anxiety and insomnia.
As far as the evidence for these uses goes, there is emerging data suggesting it may help with anxiety, it has been approved in several countries for the treatment of pain caused by inflammation, and one review found it “could improve” sleep quality, but, this is based on the limited research and too early to say for sure.
Researchers continue to explore its use in other areas.
“It’s interesting because it seems to have so many benefits for symptoms that are troubling people – weight, sleep, appetite, mood,” Martin says. However, none of the evidence for this is solid yet.
Nor is the research that has explored its use for Parkinson’s disease (“interesting evidence” but currently insufficient, according to a 2020 review paper); burnout (it can help, according to one small new study); and as a treatment for addiction (one randomised, controlled trial found it was safe and more effective than a placebo).
“A lot of the things people would like to think it’s effective for, the evidence is very slim and a lot of it is just not there at all. The evidence for and against the usefulness is coming.”
Despite the lack of good evidence, some people take CBD oil daily as a prophylactic, for sleep and reducing anxiety: the reason more than 60 per cent of CBD users took it, according to a survey of 5000 people – by a cannabis market research group – reported in The New York Times.
For now, Khorshid is unconvinced of its benefits. “Currently, there is insufficient evidence to use medicinal cannabis products more broadly and the evidence base varies across conditions. This is why there are not more medicinal cannabis products registered on the Australian Register of Therapeutic Goods,” he says.
“The TGA states that medicinal cannabis is not appropriate for individuals with an anxiety disorder. The TGA also states that there is no evidence on its effects on sleep.”
Connor says, “A lot of the things people would like to think it’s effective for, the evidence is very slim and a lot of it is just not there at all. The evidence for and against the usefulness is coming. In a few year’s time we will have a much better idea about what benefits it might have.”
A landmark study on how cannabis affects driving ability has shown that CBD does not impair driving. People who are taking CBD-only products are legally allowed to drive, although Martin urges caution given that it’s used to help people with sleep issues, and seizures. It is illegal to drive while being treated with products containing THC.
“It is quite a safe drug,” says Arnold, noting that meta-analyses have found the main problems are that it can cause diarrhoea – and that it can interact with other drugs. “That needs to be better documented, so clinicians have good guidance on how to manage those interactions.”
Martin agrees: “It does seem to have a lot of potential benefits but there’s a need to understand it more as well.”
And while CBD seems to be “generally reasonably safe in healthy people at low doses”, according to Connor, “the fact that it’s probably harmless probably means it’s not doing very much either.”
He points out that the doses to treat a condition, such as epilepsy, are much higher than people are likely to take daily.
“It’s like any drug, if you take a little, it’s probably fine … taken at higher doses it could be problematic.”
If you think CBD may benefit you, speak with your GP.
Loading
“What’s a good combination for epilepsy may not be a good combination for pain,” Connor says, and doses and combinations my differ, depending on why it’s being used. “It’s a very complex space.”
“Even if it does turn out to be effective, it’s never going to be: ‘Here, take 100 milligrams of cannabidiol and that’ll fix what ails you’.“
Fascinating answers to perplexing questions delivered to your inbox every week. Sign up to get our new Explainer newsletter here.
Jenna Bush Hager uncovered the exercise regimen she follows to feel her best. Hager explained it really is essential to recognize, “it just takes time, and you have to give yourself that grace.” Currently with Hoda & Jenna co-star Hoda Kotb inspired viewers to cease …
As an individual who has been self-utilized considering that in advance of the Great Recession, I know that financial disruptions can spell issues for unbiased contractors. So, when the pandemic commenced, I took on extra assignments to hedge towards what could be ahead. Right after …
There is “no proof ideal now” that healthy kids and adolescents need to have a booster dose to augment their COVID-19 vaccinations, in accordance to Planet Health Group (WHO) Main Scientist Dr. Soumya Swaminathan all through a media briefing on Tuesday, Jan. 18.
This arrives just 2 weeks just after the Facilities for Ailment Control and Avoidance (CDC)
For the 7 days ending January 13, in excess of 981,000 situations of COVID-19 have been noted in youngsters, a 69 percent enhance from the 7 days ahead of, according to the most current knowledge from the American Academy of Pediatrics.
Several states, including Alabama and Michigan, are also looking at a sharp increase in child COVID-19 hospitalizations.
CDC information exhibit that this maximize has been notably high in kids below the age of 5, who are not however eligible for a COVID-19 vaccine.
Other international locations, these types of as Israel and Germany, have also suggested COVID-19 booster doses for little ones ages 12 and 17.
Two doses of an mRNA COVID-19 vaccine protect small children and adolescents against critical illness — the sort that would land them in the clinic or an intensive care device.
This incorporates guarding in opposition to multisystem inflammatory syndrome in small children (MIS-C), a likely critical problem that can manifest in some kids who acquire COVID-19.
A the latest
“This healthcare affliction can make little ones very sick and place them in the intensive care unit,” explained Dr. Christina Johns, pediatrician and senior professional medical advisor for PM Pediatrics.
“The superior news is that, if [MIS-C is] caught early, young children can get well. But why place your boy or girl through that, if there is a way that’s so efficient at preventing it?” Johns claimed.
Doctors and gurus
For healthier children, Johns stated she would also recommend a booster.
“We do know that immunity [after vaccination] wanes over time,” she said, “so offering [adolescents] a booster is not an unreasonable point to do.”
Most COVID-19 situations that take place in thoroughly vaccinated children will be delicate, but a booster dose can supply added protection against transmission.
“With the [high] presence of Omicron, we are seeking to be quite mindful and enhance everyone we can,” mentioned Dr. Judith Flores, a pediatrician in Brooklyn, New York.
Boosters also secure other individuals who are all over youngsters — older family members members and neighbors, other children with weakened immune methods, and little ones beneath age 5 who can’t get vaccinated still.
“The primary thing is to make confident that little ones — and adults — who are vulnerable get the major vaccine series,” said Flores, “but they likely really should get boosted in addition.”
While Johns has no protection considerations about booster doses for youngsters ages 12 and more mature, she said if mother and father have any issues or problems, they should really speak with their child’s pediatrician.
Swaminathan mentioned for the duration of the WHO media briefing that the agency’s
“The goal [with boosters] is to guard the most vulnerable, to shield people at maximum hazard of extreme ailment and dying,” she mentioned. “Those are our elderly populations, immunocompromised individuals with fundamental conditions, but also healthcare staff.”
General, 60 {b574a629d83ad7698d9c0ca2d3a10ad895e8e51aa97c347fc42e9508f0e4325d} of the world’s populace have gained at minimum 1 dose of a COVID-19 vaccine, in accordance to Our Planet in Knowledge.
Nevertheless, this drops to below 10 per cent in low revenue international locations — a about statistic which is driving the WHO’s force to safeguard these most at danger before rolling out boosters to healthier populations.
“Our focus, taking into consideration that we however have so several unvaccinated men and women in the world, is to… supply most important doses to those who have not been vaccinated… even though at the identical time hoping to guard the most vulnerable in each country’s inhabitants,” explained Swaminathan through the media briefing.
Even so, even in the United States, there are quite a few men and women who are unvaccinated, with small children and young older people getting the least vaccinated sections of the inhabitants.
Extra than 70 p.c of 5- to 11-calendar year-olds in the United States — and around 34 p.c of 12- to 17-calendar year-olds — have not acquired a solitary dose, according to data from the Mayo Clinic.
“We don’t have more than enough children vaccinated with the main sequence,” explained Flores, “which is my aim when I get care of clients and people.”